Cidara Therapeutics, Inc.

CIK 1610618 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Cidara Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Feb 17, 2026SCHEDULE 13G/A0001193125-26-054780
Feb 17, 2026SCHEDULE 13G/A0000902664-26-001143
Feb 13, 2026SCHEDULE 13G/A0001213900-26-016647
Jan 30, 2026SCHEDULE 13G0000102909-26-000047
Jan 20, 202615-12G0001193125-26-015957
Jan 9, 2026EFFECT9999999995-26-000126
Jan 9, 2026EFFECT9999999995-26-000122
Jan 9, 2026EFFECT9999999995-26-000124
Jan 9, 2026EFFECT9999999995-26-000121
Jan 9, 2026EFFECT9999999995-26-000123
Jan 9, 2026SCHEDULE 13D/A0001346824-26-000004
Jan 9, 202640001231919-26-000031
Jan 9, 2026EFFECT9999999995-26-000120
Jan 7, 2026POS AM0001193125-26-005766
Jan 7, 2026POS AM0001193125-26-005782
Jan 7, 2026SC TO-T/A0001193125-26-005513
Jan 7, 2026S-8 POS0001193125-26-005821
Jan 7, 2026S-8 POS0001193125-26-005791
Jan 7, 2026S-8 POS0001193125-26-005846
Jan 7, 202625-NSE0001354457-26-000017
Jan 7, 2026SC 14D9/A0001193125-26-005515
Jan 7, 2026POS AM0001193125-26-005773
Jan 7, 2026S-8 POS0001193125-26-005799
Jan 7, 2026POS AM0001193125-26-005769
Jan 7, 20268-K0001193125-26-005517